Biologics
Fayetteville, US · Delaware corporation · 3 known investors
BiologicsMD is a preclinical therapeutic company developing patent-protected recombinant fusion proteins that target the parathyroid hormone receptor for treatments in hair loss, bone disorders, and oncology. Its proteins combine an active stimulatory domain with a binding domain to localize therapy at the disease site for targeted, infrequent dosing.
Founders & leadership
JD
J. David OwensExecutive
RG
Robyn GoforthNamed on SEC filing
RG
Rob GensureNamed on SEC filing
Board
RB
Ramsay BallBoard director
CG
Calvin GoforthBoard director
LK
Lynn KirkpatrickBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$400K disclosed across 1 round · 2016
▶$400KraisedFeb 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$400KraisedFeb 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ramsay BallDirector
- Robyn GoforthExecutive Officer
- Calvin GoforthDirector, Promoter
- Rob GensureExecutive Officer
- J. David OwensExecutive Officer, Director
- Lynn KirkpatrickDirector
- Offering amount
- $7M
- Amount sold
- $400K
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapMacrogenics Inc6 shared keywordsMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
Abiologics4 shared keywordsAbiologics uses computational design tools to create protein-inspired molecules called Synteins, engineered to avoid the vulnerabilities of natural protein medicines while retaining biological function. The company develops these molecules as a new class of therapeutics with the aim of advancing candidates toward clinical development.
AdvanceCT4 shared keywordsAdvanceCT is a nonprofit economic development organization that drives job creation and capital investment in Connecticut through business attraction, retention, and expansion. It works with state and local partners to support inclusive business development and provide companies with resources, workforce solutions, and research.
Companies competing with Biologics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Biologics do?
- BiologicsMD is a preclinical therapeutic company developing patent-protected recombinant fusion proteins that target the parathyroid hormone receptor for treatments in hair loss, bone disorders, and oncology. Its proteins combine an active stimulatory domain with a binding domain to localize therapy at the disease site for targeted, infrequent dosing.
- Who are Biologics's investors?
- Biologics's investors include Connecticut Innovations, Houston Angel Network, Robin Hood Ventures.
- How much funding has Biologics raised?
- Biologics has disclosed $400K raised across 1 round.
- Where is Biologics headquartered?
- Biologics is headquartered in Fayetteville, US.